Abstract：Objective To analyze the drug resistance of multidrug-resistant organism (MDRO) among hospitalized children in a children's hospital in Hebei Province from 2019 to 2023, so as to provide the basis for the rational clinical application of antibacterial drugs. Methods Specimens including sputum, blood, urine, pus, bronchoalveolar lavage fluid, secretions, pleural fluid, and peritoneal fluid of hospitalized children from January 2019 to December 2023 were collected. Pathogen identification and drug susceptibility tests were performed on methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum β-lactamase-producing Escherichia coli (ESBLs-EC), extended-spectrum β-lactamase-producing Klebsiella pneumoniae (ESBLs-KP), carbapenem-resistant Klebsiella pneumoniae (CRKP), carbapenem-resistant Acinetobacter baumannii (CRAB), carbapenem-resistant Pseudomonas aeruginosa (CRPA) and carbapenem-resistant Escherichia coli (CREC). The department distribution, specimen distribution, and drug resistance of MDROs were analyzed. Results A total of 279 086 samples were submitted for testing, with 3 512 MDROs detected. Among these, MRSA and ESBLs-EC had relatively high detection rates of 35.76% and 41.50%, respectively. In the internal medicine pediatric patients, 1 869 MDROs were detected, accounting for 53.22%. The main departments were respiratory medicine, neonatology, and intensive care. In the surgical department, 1 643 MDROs were detected, accounting for 46.78%, with the main sources being general surgery and cardiac surgery. The highest numbers of MDROs were detected in sputum, pus, and urine samples, with 1 372, 527, and 494 isolates, representing 39.07%, 15.01%, and 14.07%, respectively. The resistance rates of MRSA to penicillin, oxacillin, and erythromycin were between 81.76% and 100.00%. ESBLs-EC and ESBLs-KP had a resistance rate of 100.00% to ceftriaxone. CRKP had a resistance rate of 100.00% to ampicillin/sulbactam and imipenem. CRAB had a resistance rate of 100.00% to cefoxitin, imipenem, and meropenem. CRPA had a resistance rate of 100.00% to ampicillin/sulbactam, ceftriaxone, cefoxitin, and imipenem. CREC had a resistance rate of 100.00% to imipenem. Conclusions In a children's hospital in Hebei Province, infections with MDROs among hospitalized pediatric patients are primarily caused by MRSA and ESBLs-EC. These infections are mainly distributed in the departments of respiratory medicine, neonatology, intensive care, general surgery, and cardiac surgery, with the highest detection rates in sputum, pus, and urine samples. Additionally, MRSA, ESBLs-EC, ESBLs-KP, CRKP, CRAB, CRPA, and CREC show high resistance rate to most antimicrobial agents.
孙玲, 刘元青, 刘新光, 张楠, 温婵, 郝建宗, 李梅. 河北省某儿童医院住院患儿多重耐药菌耐药性分析[J]. 预防医学, 2025, 37(6): 616-621.
SUN Ling, LIU Yuanqing, LIU Xinguang, ZHANG Nan, WEN Chan, HAO Jianzong, LI Mei. Drug resistance of multidrug-resistant organism in hospitalized children at a children's hospital in Hebei Province. Preventive Medicine, 2025, 37(6): 616-621.
[1] COLLABORATORS G A R.Global burden of bacterial antimicrobial resistance 1990-2021:a systematic analysis with forecasts to 2050[J].Lancet,2024,404(10459):1199-1226. [2] 杨昊,刘长秀,李童.2018—2020年岳阳市儿童常见多重耐药菌感染及耐药性分析[J].甘肃医药,2023,42(10):897-899. YANG H,LIU C X,LI T.Analysis of common multidrug-resistant bacterial infections and drug resistance in children in Yueyang City from 2018 to 2020[J].Gansu Med J,2023,42(10):897-899.(in Chinese) [3] 张丽,孙雪荣,徐莉莉,等.2019—2021年住院儿童多重耐药菌分布及耐药性分析[J].青岛大学学报(医学版),2023,59(5):735-739. ZHANG L,SUN X R,XU L L,et al.An analysis of distribution and drug resistance of multidrug-resistant organisms in hospitalized children from 2019 to 2021[J].J Qingdao Univ(Med Sci),2023,59(5):735-739.(in Chinese) [4] 中华人民共和国国家卫生健康委员会.临床微生物学检验标本的采集和转运:WS/T 640—2018[S].2018. National Health Commission of the People's Republic of China.Specimen collection and transport in clinical microbiology:WS/T 640—2018[S].2018.(in Chinese) [5] 尚红,王毓三,申子瑜.全国临床检验操作规程(第四版)[M].北京:人民卫生出版社,2015. SHANG H,WANG Y S,SHEN Z Y.National Clinical Laboratory Procedures (4th edition)[M].Beijing:People's Medical Publishing House,2015.(in Chinese) [6] M100-S33 Clinical and Laboratory Standards Institute.Performance standards for antimicrobial susceptibility testing[S].2023. [7] 中华人民共和国国家卫生健康委员会.医院感染监测标准:WS/T 312—2023[S].2023. National Health Commission of the People's Republic of China.Hospital infection surveillance standards:WS/T 312—2023[S].2023.(in Chinese) [8] 刘慧萍,王俊,高凯杰.2016—2020年某三甲儿童医院耐甲氧西林金黄色葡萄球菌分布及耐药性分析[J].实用预防医学,2022,29(8):1004-1007. LIU H P,WANG J,GAO K J.Analysis of the distribution and drug resistance of methicillin-resistant Staphylococcus aureus in a tertiary children's hospital from 2016 to 2020[J].Pract Prev Med,2022,29(8):1004-1007.(in Chinese) [9] 付盼,王传清,俞蕙,等.中国儿童细菌耐药监测组2023年儿童细菌耐药监测[J].中国循证儿科杂志,2024,19(4):272-280. FU P,WANG C Q,YU H,et al.Antimicrobial resistance profile of clinical strains isolated from children in China:a report from the ISPED program 2023[J].Chin J Evid Based Pediatr,2024,19(4):272-280.(in Chinese) [10] GUMUS D D,DEMIR O O,AYKAC K,et al.Gram-negative bacteremia,the risk factors,and outcome in children[J/OL].Diagn Microbiol Infect Dis,2024,109(3)[2025-03-05].https://doi.org/10.1016/j.diagmicrobio.2024.116324. [11] BEDZICHOWSKA A,PRZEKORA J,STAPINSKA-SYNIEC A,et al.Frequency of infections caused by ESBL-producing bacteria in a pediatric ward-single-center five-year observation[J].Arch Med Sci,2019,15(3):688-693. [12] 孙卫锋,吕锐,胡喜荣,等.老年住院脑卒中患者医院获得性肺炎病原菌分布及耐药性分析[J].预防医学,2021,33(12):1256-1259. SUN W F,LYU R,HU X R,et al.Distribution and drug resistance of hospital-acquired pneumonia pathogens in elderly stroke patients[J].China Prev Med J,2021,33(12):1256-1259.(in Chinese) [13] 何建春,裴昌贞,杨雷,等.近5年某院MRSA检出率、流行病学及耐药机制研究[J].国际检验医学杂志,2024,45(4):480-485. HE J C,PEI C Z,YANG L,et al.Study on the detection rate,epidemiology and resistance mechanism of MRSA in a hospital in recent 5 years[J]. Int J Lab Med,2024,45(4):480-485.(in Chinese) [14] 黄辉,魏佳,申汉俊,等.2017—2022年江苏省某儿童医院ICU患儿痰培养病原菌分布及耐药性变迁的分析[J].中华预防医学杂志,2024,58(10):1534-1540. HUANG H,WEI J,SHEN H J,et al.Analysis of the changes of bacterial spectrum and drug resistance in sputum culture of ICU children in a hospital of pediatric in Jiangsu Province from 2017 to 2022[J].Chin J Prev Med,2024,58(10):1534-1540.(in Chinese) [15] BRENNAN-KROHN T,MANETSCH R,O'DOHERTY G A,et al.New strategies and structural considerations in development of therapeutics for carbapenem-resistant Enterobacteriaceae[J].Transl Res,2020,220:14-32. [16] WANG L X,GUO H,QU L Y,et al.Distribution and drug resistance of common pathogens causing lower respiratory tract infection in Xinjiang Region[J].Altern Ther Health Med,2024,30(11):399-403. [17] VERKAIK N J,WIELDERS C,DEN BOER H,et al.Antimicrobial susceptibility to last-resort antibiotics in carbapenemase-producing bacteria from Ukrainian patients[J/OL].Microbiol Spectr,2024[2025-03-05].https://doi.org/10.1128/spectrum.01142-24. [18] BIAN X C,LI M Y,LIU X F,et al.Transcriptomic investigations of polymyxins and colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii[J].Comput Struct Biotechnol J,2024,23:2595-2605. [19] SELIM H,GOMAA F,ALSHAHRANI M Y,et al.Colistin,doxycycline and Labetalol-meropenem combination are the most active against XDR-Carbapenem-resistant Acinetobacter baumannii:role of a novel transferrable plasmid conferring carbapenem resistance[J/OL].Diagn Microbiol Infect Dis,2024,110(4)[2025-03-05].https://doi.org/10.1016/j.diagmicrobio.2024.116558. [20] 武文君,王炜,陈明心,等.某三甲中医院耐碳青霉烯类铜绿假单胞菌临床分离株耐药性和同源性[J].中华医院感染学杂志,2024,34(22):3376-3381. WU W J,WANG W,CHEN M X,et al.Drug resistance and homology of clinical carbapenem-resistant Pseudomonas aeruginosa isolates from a three-a traditional Chinese medicine hospital[J].Chin J Nosocomio,2024,34(22):3376-3381.(in Chinese)
